rocuronium and Hepatitis-C

rocuronium has been researched along with Hepatitis-C* in 1 studies

Other Studies

1 other study(ies) available for rocuronium and Hepatitis-C

Article	Year
Sugammadex antagonising rocuronium in three patients with liver dysfunction undergoing transjugular intrahepatic portosystemic shunt. Anaesthesia and intensive care, 2012, Volume: 40, Issue:3 Topics: Adult; Androstanols; Anesthesia Recovery Period; Budd-Chiari Syndrome; Female; gamma-Cyclodextrins; Hepatitis C; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Male; Middle Aged; Monitoring, Intraoperative; Neuromuscular Nondepolarizing Agents; Portasystemic Shunt, Transjugular Intrahepatic; Rocuronium; Sugammadex	2012

Article

Year

Sugammadex antagonising rocuronium in three patients with liver dysfunction undergoing transjugular intrahepatic portosystemic shunt.

Anaesthesia and intensive care, 2012, Volume: 40, Issue:3

Topics: Adult; Androstanols; Anesthesia Recovery Period; Budd-Chiari Syndrome; Female; gamma-Cyclodextrins; Hepatitis C; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Male; Middle Aged; Monitoring, Intraoperative; Neuromuscular Nondepolarizing Agents; Portasystemic Shunt, Transjugular Intrahepatic; Rocuronium; Sugammadex

2012